Lindsay Morrell, MD
Obstetrics & Gynecology · Towson, MDNPI 1942561519
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 9.3% — the pattern of someone who eats at a lot of different presentations.
Across 184 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$303
- Exeltis, USA Inc.$271
- Myovant Sciences Inc.$250
- Astellas Pharma US Inc$249
- Mayne Pharma Commercial LLC$201
- Pfizer$186
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,14596%
- Education$1194%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $303 |
| Exeltis, USA Inc. | 14 | $271 |
| Myovant Sciences Inc. | 15 | $250 |
| Astellas Pharma US Inc | 16 | $249 |
| Mayne Pharma Commercial LLC | 16 | $201 |
| Pfizer | 9 | $186 |
| Organon | 8 | $173 |
| Therapeuticsmd, Inc. | 7 | $140 |
| Coopersurgical, Inc. | 7 | $116 |
| Avion Pharmaceuticals | 9 | $114 |
| AMAG Pharmaceuticals, Inc. | 6 | $106 |
| Bayer | 6 | $105 |
| Merck | 6 | $103 |
| Shield Therapeutics Inc | 4 | $100 |
| Evofem Biosciences, Inc. | 6 | $99 |
| Daiichi Sankyo Inc. | 4 | $97 |
| Sage Therapeutics, LLC | 4 | $96 |
| Millicent US Inc | 6 | $91 |
| Sumitomo Pharma America, Inc. | 5 | $87 |
| Aspira Women's Health Inc | 4 | $69 |
| Scynexis, Inc. | 2 | $48 |
| Duchesnay USA Incorporated | 2 | $45 |
| Innovation Technologies Inc | 1 | $41 |
| Lupin Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Smith+Nephew | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Mycovia Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$3,264 in reported general payments places this provider in the 85th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $2,680 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Towson
- Anna PowellTowson$13K
- Otis StittSilver Spring$641K
- Danielle ShillerBaltimore$221K
- Matthew ReevesChevy Chase$149K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Abigail GregoryOakland$63K
- Christina EnzmannBaltimore$63K
- Lisa RarickChesapeake Beach$54K
- Logan PetersonBethesda$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.